Boiron SA (BOI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Boiron SA (BOI) has a cash flow conversion efficiency ratio of 0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€27.52 Million ≈ $32.17 Million USD) by net assets (€392.78 Million ≈ $459.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BOI market cap for the company's overall valuation and market capitalisation.
Boiron SA - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Boiron SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Boiron SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Boiron SA ranked by their cash flow conversion efficiency. Explore Boiron SA cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kumyang
KO:001570
|
0.000x |
|
VITZROCELL Co.Ltd
KQ:082920
|
0.049x |
|
Frontera Energy Corp
TO:FEC
|
-0.019x |
|
Prime Energy PE Ltd
TA:PRIM
|
-0.084x |
|
Hiper Global Ltd
TA:HIPR
|
-0.170x |
|
Kerry TJ Logistics Co Ltd
TW:2608
|
0.057x |
|
Baolingbao Biology Co Ltd
SHE:002286
|
0.059x |
|
Sappi Ltd
JSE:SAP
|
0.023x |
Annual Cash Flow Conversion Efficiency for Boiron SA (2001–2025)
The table below shows the annual cash flow conversion efficiency of Boiron SA from 2001 to 2025. View latest Boiron SA stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €392.78 Million ≈ $459.20 Million |
€53.24 Million ≈ $62.24 Million |
0.136x | +29.67% |
| 2024-12-31 | €378.18 Million ≈ $442.14 Million |
€39.53 Million ≈ $46.22 Million |
0.105x | -10.04% |
| 2023-12-31 | €391.50 Million ≈ $457.70 Million |
€45.49 Million ≈ $53.18 Million |
0.116x | +10.35% |
| 2022-12-31 | €557.35 Million ≈ $651.60 Million |
€58.69 Million ≈ $68.61 Million |
0.105x | +68.07% |
| 2021-12-31 | €531.77 Million ≈ $621.70 Million |
€33.32 Million ≈ $38.95 Million |
0.063x | -53.27% |
| 2020-12-31 | €509.17 Million ≈ $595.27 Million |
€68.27 Million ≈ $79.81 Million |
0.134x | +33.25% |
| 2019-12-31 | €505.46 Million ≈ $590.94 Million |
€50.86 Million ≈ $59.46 Million |
0.101x | -41.95% |
| 2018-12-31 | €486.04 Million ≈ $568.24 Million |
€84.25 Million ≈ $98.50 Million |
0.173x | -14.36% |
| 2017-12-31 | €517.49 Million ≈ $605.00 Million |
€104.75 Million ≈ $122.46 Million |
0.202x | -13.69% |
| 2016-12-31 | €469.60 Million ≈ $549.01 Million |
€110.13 Million ≈ $128.75 Million |
0.235x | -5.42% |
| 2015-12-31 | €416.04 Million ≈ $486.40 Million |
€103.16 Million ≈ $120.61 Million |
0.248x | -2.04% |
| 2014-12-31 | €379.88 Million ≈ $444.12 Million |
€96.16 Million ≈ $112.42 Million |
0.253x | -7.32% |
| 2013-12-31 | €391.86 Million ≈ $458.12 Million |
€107.02 Million ≈ $125.11 Million |
0.273x | +9.17% |
| 2012-12-31 | €354.16 Million ≈ $414.05 Million |
€88.59 Million ≈ $103.58 Million |
0.250x | +56.78% |
| 2011-12-31 | €368.65 Million ≈ $430.99 Million |
€58.82 Million ≈ $68.77 Million |
0.160x | +6.24% |
| 2010-12-31 | €343.84 Million ≈ $401.99 Million |
€51.64 Million ≈ $60.37 Million |
0.150x | -41.34% |
| 2009-12-31 | €313.28 Million ≈ $366.25 Million |
€80.20 Million ≈ $93.76 Million |
0.256x | +6.15% |
| 2008-12-31 | €271.49 Million ≈ $317.40 Million |
€65.48 Million ≈ $76.55 Million |
0.241x | +7.40% |
| 2007-12-31 | €249.94 Million ≈ $292.21 Million |
€56.13 Million ≈ $65.62 Million |
0.225x | +33.97% |
| 2006-12-31 | €230.09 Million ≈ $268.99 Million |
€38.57 Million ≈ $45.09 Million |
0.168x | -7.68% |
| 2005-12-31 | €229.88 Million ≈ $268.75 Million |
€41.74 Million ≈ $48.80 Million |
0.182x | -23.95% |
| 2004-12-31 | €144.09 Million ≈ $168.46 Million |
€34.40 Million ≈ $40.22 Million |
0.239x | -2.79% |
| 2003-12-31 | €149.53 Million ≈ $174.82 Million |
€36.73 Million ≈ $42.94 Million |
0.246x | -4.17% |
| 2002-12-31 | €134.47 Million ≈ $157.20 Million |
€34.46 Million ≈ $40.29 Million |
0.256x | -8.21% |
| 2001-12-31 | €119.17 Million ≈ $139.32 Million |
€33.27 Million ≈ $38.90 Million |
0.279x | -- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more